Gene-environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies
- PMID: 30536881
- PMCID: PMC6767750
- DOI: 10.1002/ijc.32057
Gene-environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta-analyses of observational studies
Abstract
The cause of colorectal cancer (CRC) is multifactorial, involving both genetic variants and environmental risk factors. We systematically searched the MEDLINE, EMBASE, China National Knowledge Infrastructure (CNKI) and Wanfang databases from inception to December 2016, to identify systematic reviews and meta-analyses of observational studies that investigated gene-environment (G×E) interactions in CRC risk. Then, we critically evaluated the cumulative evidence for the G×E interactions using an extension of the Human Genome Epidemiology Network's Venice criteria. Overall, 15 articles reporting systematic reviews of observational studies on 89 G×E interactions, 20 articles reporting meta-analyses of candidate gene- or single-nucleotide polymorphism-based studies on 521 G×E interactions, and 8 articles reporting 33 genome-wide G×E interaction analyses were identified. On the basis of prior and observed scores, only the interaction between rs6983267 (8q24) and aspirin use was found to have a moderate overall credibility score as well as main genetic and environmental effects. Though 5 other interactions were also found to have moderate evidence, these interaction effects were tenuous due to the lack of main genetic effects and/or environmental effects. We did not find highly convincing evidence for any interactions, but several associations were found to have moderate strength of evidence. Our conclusions are based on application of the Venice criteria which were designed to provide a conservative assessment of G×E interactions and thus do not include an evaluation of biological plausibility of an observed joint effect.
Keywords: colorectal cancer; diet; environment; gene; interaction; risk factor.
© 2018 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Conflict of interest statement
None declared.
Figures
References
-
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. - PubMed
-
- Tze CN, Fitzgerald H, Qureshi A, et al. Pioneering annual colorectal cancer screening and treatment targeting Low income communities in Malaysia (20102015). Asian Pac J Cancer Prev 2016;17:3179–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R35 CA197735/NH/NIH HHS/United States
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- CA074799U01/U24/CA/NCI NIH HHS/United States
- U01 CA167551/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 CA074783/CA/NCI NIH HHS/United States
- HHSN268201100002C/HL/NHLBI NIH HHS/United States
- G0600329/MRC_/Medical Research Council/United Kingdom
- K05 CA154337/NH/NIH HHS/United States
- P50 CA127003/NH/NIH HHS/United States
- R01 CA60987/NH/NIH HHS/United States
- K07 CA190673/NH/NIH HHS/United States
- R01 CA042182/NH/NIH HHS/United States
- MC_UU_00007/1/MRC_/Medical Research Council/United Kingdom
- 22804/CRUK_/Cancer Research UK/United Kingdom
- CA074778U01/CA/NCI NIH HHS/United States
- P01 CA087969/NH/NIH HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- CA015704R01/CA/NCI NIH HHS/United States
- HHSN271201100004C/HL/NHLBI NIH HHS/United States
- MC_PC_U127527198/MRC_/Medical Research Council/United Kingdom
- CA074800U01/U24/CA/NCI NIH HHS/United States
- CA074806U01/U24/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- Z01 CP 010200/NH/NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- P01 CA055075/NH/NIH HHS/United States
- U01 HG004446/NH/NIH HHS/United States
- UM1 CA186107/NH/NIH HHS/United States
- 12076/CRUK_/Cancer Research UK/United Kingdom
- CA143247R01201407U01/CA/NCI NIH HHS/United States
- CA167551/CA/NCI NIH HHS/United States
- C31250/A22804C348/A18927/CRUK_/Cancer Research UK/United Kingdom
- R01 CA48998/NH/NIH HHS/United States
- U01 HG 004438/NH/NIH HHS/United States
- R37 CA54281/NH/NIH HHS/United States
- MC_U127527198/MRC_/Medical Research Council/United Kingdom
- CA074783U01/U24/CA/NCI NIH HHS/United States
- HHSN261201300011C/RC/CCR NIH HHS/United States
- HHSN261201300012I/CA/NCI NIH HHS/United States
- CA137088P30/CA/NCI NIH HHS/United States
- U01 CA167552/NH/NIH HHS/United States
- CA097735UM1/CA/NCI NIH HHS/United States
- HHSN268201100003C/HL/NHLBI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- MR/K018647/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201100001C/HL/NHLBI NIH HHS/United States
- 18927/CRUK_/Cancer Research UK/United Kingdom
- R01 CA151993/NH/NIH HHS/United States
- CA074794U01/U24/CA/NCI NIH HHS/United States
- HHSN261201300021C/CA/NCI NIH HHS/United States
- HHSN268201100004C/HL/NHLBI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- UM1 CA167552/NH/NIH HHS/United States
- U01 CA074783/NH/NIH HHS/United States
- P01 CA033619/NH/NIH HHS/United States
- R01 CA137178/NH/NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- CA122839U01/U24/CA/NCI NIH HHS/United States
- R01 CA063464/NH/NIH HHS/United States
- G0600237/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
